Florian Hohla
Salzburg, 5020, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients.
Journal: Future science OA
Published: January 13, 2021
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.
Journal: The Lancet. Oncology
Published: January 08, 2016
Cytomegalovirus reactivation and its clinical impact in patients with solid tumors.
Journal: Infectious agents and cancer
Published: January 26, 2015
Gender- and site-specific differences of colorectal neoplasia relate to vitamin D.
Journal: Alimentary pharmacology & therapeutics
Published: July 28, 2014
Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians.
Journal: Acta diabetologica
Published: January 22, 2014
Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125.
Journal: BMC cancer
Published: November 19, 2013
Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectives.
Journal: World journal of gastroenterology
Published: October 07, 2013
71-year old woman with neutropenic fever during chemotherapy
Journal: Deutsche medizinische Wochenschrift (1946)
Published: October 03, 2013
Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review.
Journal: International journal of oncology
Published: August 25, 2013
Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report.
Journal: BMC cancer
Published: August 25, 2013
Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
Journal: Oncology reports
Published: March 11, 2013
GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.
Journal: Cell cycle (Georgetown, Tex.)
Published: October 26, 2012
Last Updated: 09/26/2026